Home/SEC 13D/G/TNGXSEC 13D/GTNGX - Tango Therapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks Simplified$TNGX$26.26▲ 193.74% YTDHealthcareAug 12, 2026 · ThinkSabio BlogSEC Filing Update: #TNGX Tango Therapeutics, Inc. : $26.26 Sector: Healthcare | YTD: 🔼+ 193.74% The SEC disclosed Today (12-AUG-2026) that Adage Capital Management, L.P. has DECREASED #TNGX Shares by -56.28% 🔴 * Previous Holdings: 12.81M Shares * Current Holdings: 5.60M Shares * Decrease -7.21M * Decreased (%)-56.28% * Ownership: 3.44% https://www.thinksabio.com/reports/isr/TNGX Institutional ownership in #TNGX has been steadily rising over the past 12 quarters in Shares: Q4 2023: 93.64M Q1 2024: 98.40M Q2 2024: 98.60M Q3 2024: 101.47M Q4 2024: 106.44M Q1 2025: 107.29M Q2 2025: 127.26M Q3 2025: 139.98M Q4 2025: 172.39M Q1 2026: 180.26M The quarterly average prices of #TNGX: Q2 2025: $2.47 Q3 2025: $6.77 Q4 2025: $8.62 Q1 2026: $13.92 Share this post🔗Copy Link💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G